Find latest Skin videos · 200+ videos
2024 ASCO® Annual Meeting Insights Hub
H

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunotherapy - Pre-op, Post-op or No-op? NADINA Trial Discussion"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harriet Kluger
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harriet Kluger
125 views
June 10, 2024

Chapters

Overview & NADINA Trial Introduction

00:00

Neoadjuvant vs. Adjuvant Therapy Comparison

00:59

Event-Free Survival & Treatment Rationale

01:51

Adjuvant Therapy Evolution & Current Options

04:28

Immune-Related Adverse Events & Quality of Life

07:42

Comments 0
Login to view comments. Click here to Login

Related Videos

09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

352 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.0K views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

811 views
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

213 views
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

737 views
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

583 views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

269 views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

816 views
15:49

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

179 views
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

198 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

518 views
09:07

New

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

115 views
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

433 views
17:01

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

110 views
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

474 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

423 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

41 views
14:32

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

127 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

327 views
AUTOPLAY